TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22801294

Group type: EXPERIMENTAL
Intervention: Pramipexole extended-release (ER) once daily for 12 weeks, titrated to a maximum daily dose of 4.5 mg
Number of subjects: 112

Group type: COMPARATOR
Intervention: Pramipexole immediate-release (IR) 2 to 3 times daily for 12 weeks, titrated to a maximum daily dose of 4.5 mg
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Open-label pramipexole ER after switching from IR
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Both ER and IR formulations
Number of subjects: 112
Study: 20530645

Group type: EXPERIMENTAL
Intervention: Constraint-induced movement therapy (affected arm trained for 3 hours/day, non-affected arm restricted for 10 hours/day for two weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (usual rehabilitation)
Number of subjects: 16
Study: 17626023

Group type: EXPERIMENTAL
Intervention: Intervention group (GPs receiving the educational intervention)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (GPs not receiving the educational intervention)
Number of subjects: 104
Study: 14693782

Group type: EXPERIMENTAL
Intervention: Brimonidine 0.2%
Number of subjects: 59

Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 59
Study: 12224977

Group type: EXPERIMENTAL
Intervention: Topical 5% imiquimod cream applied once daily for 7 days per week for 6 weeks
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Topical 5% imiquimod cream applied once daily for 7 days per week for 12 weeks
Number of subjects: 191

Group type: COMPARATOR
Intervention: Vehicle cream (placebo) applied once daily for 3, 5, or 7 days per week, or twice daily for 7 days per week for 12 weeks
Number of subjects: 191
Study: 9853487

Group type: EXPERIMENTAL
Intervention: Cemented fixation
Number of subjects: 139

Group type: COMPARATOR
Intervention: Cementless fixation
Number of subjects: 139
Study: 7978560

Group type: EXPERIMENTAL
Intervention: Nebulized albuterol treatments (1990)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (1988)
Number of subjects: 176
Study: 2687818

Group type: EXPERIMENTAL
Intervention: Immucytal
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 4577015

Group type: EXPERIMENTAL
Intervention: Extradural corticosteroid injection
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study: 31722314

Group type: EXPERIMENTAL
Intervention: Ropinirole hydrochloride extended-release tablets
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 28671495

Group type: EXPERIMENTAL
Intervention: Modified classical music
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Original classical music
Number of subjects: 74

Group type: COMPARATOR
Intervention: No music (control)
Number of subjects: 74
Study: 25966608

Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 119

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 119
Study: 22777149

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg/day
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Pravastatin 10 mg/day
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 33
Study: 21751288

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (0.1 mmol/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Gadoxetic acid (0.05 mmol/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Gadoxetic acid
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine
Number of subjects: 10
Study: 18160390

Group type: EXPERIMENTAL
Intervention: 18-hour pre-study training course on knowledge about lactation and guidance for breastfeeding
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Mothers receiving support from health visitors who completed the training course
Number of subjects: 109
Study: 16585298

Group type: EXPERIMENTAL
Intervention: The Asthma Files, an interactive CD‐ROM for children with asthma
Number of subjects: 101

Group type: COMPARATOR
Intervention: Asthma information booklet alone
Number of subjects: 101
Study: 15296365

Group type: EXPERIMENTAL
Intervention: Pneumatherm
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Moist heat pack
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 11128567

Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Metoclopramide (1.5 mg/kg, i.v.)
Number of subjects: 149
Study: 9060534

Group type: EXPERIMENTAL
Intervention: 10 Gy boost to the tumor bed
Number of subjects: 1024

Group type: COMPARATOR
Intervention: No further treatment (control group)
Number of subjects: 1024
Study: 8328095

Group type: EXPERIMENTAL
Intervention: Spontaneous pushing (closed glottis technique)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Open glottis technique
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Spontaneous bearing down efforts
Number of subjects: 350

Group type: COMPARATOR
Intervention: Forced pushing (closed glottis technique)
Number of subjects: 350
Study: 2873741

Group type: EXPERIMENTAL
Intervention: Special-intervention (SI) program aimed at reducing serum cholesterol levels, blood pressure, and cigarette smoking
Number of subjects: 12866

Group type: EXPERIMENTAL
Intervention: Special-intervention (SI) program
Number of subjects: 12866

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 12866
Study: 30646083

Group type: EXPERIMENTAL
Intervention: Problem-solving education (PSE)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Usual Head Start services (control)
Number of subjects: 230
Study: 26303665

Group type: EXPERIMENTAL
Intervention: Electrical stimulation in the bed nucleus of the stria terminalis (BST)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Electrical stimulation in the anterior limbs of the internal capsule (ALIC)
Number of subjects: 24
Study: 25536218

Group type: EXPERIMENTAL
Intervention: Incobotulinumtoxin A
Number of subjects: 10
Study: 22763815

Group type: EXPERIMENTAL
Intervention: Tacrolimus and prednisolone
Number of subjects: 131

Group type: COMPARATOR
Intervention: Cyclophosphamide and prednisolone
Number of subjects: 131

Group type: COMPARATOR
Intervention: Cyclophosphamide
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 131
Study: 20028444

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% (50 microg/mL) ophthalmic solution applied nightly to eyelid margins
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group receiving triamcinolone acetonide (TAC) injections
Number of subjects: 54
Study: 17894912

Group type: EXPERIMENTAL
Intervention: Ketamine (intraoperative bolus of 0.15 mg kg‐1, followed by 0.5 mg per morphine 1 mg in a patient‐controlled analgesia device)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ketamine (as above)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 90
Study: 15837984

Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy (SNB) using radioactive colloid, lymphazurin blue dye, or both
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy (SNB) using radioisotope
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy (SNB)
Number of subjects: 428
Study: 12190090

Group type: EXPERIMENTAL
Intervention: Eradication therapy with omeprazole for 3 months
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo antibiotics with omeprazole for 3 months
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Eradication therapy in patients with antrum-predominant gastritis
Number of subjects: 143

Group type: COMPARATOR
Intervention: Ongoing infection in controls with antrum-predominant gastritis
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: High urease activity of the stomach
Number of subjects: 143
Study: 10520210

Group type: EXPERIMENTAL
Intervention: First-degree relatives of early onset lung cancer cases
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Relatives of cases with adenocarcinoma of the lung
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Relatives of cases
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Case families
Number of subjects: 384
Study: 8625221

Group type: EXPERIMENTAL
Intervention: Octreotide 150 micrograms subcutaneously three times daily
Number of subjects: 260

Group type: COMPARATOR
Intervention: Saline placebo injections
Number of subjects: 260
Study: 2205768

Group type: EXPERIMENTAL
Intervention: Prior notification process used in firm trials
Number of subjects: 0
Study: 7384318

Group type: EXPERIMENTAL
Intervention: Follow-up care (3 forms)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Seropositive patients
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Self-rating as 'slow, dependent, and weak'
Number of subjects: 129
Study: 30981962

Group type: EXPERIMENTAL
Intervention: Semi-rigid ankle brace (T1)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Softshell ankle brace (AE)
Number of subjects: 42

Group type: COMPARATOR
Intervention: No brace
Number of subjects: 42
Study: 28334999

Group type: EXPERIMENTAL
Intervention: Verum electro-acupuncture 'local' to the more affected hand
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Verum electro-acupuncture at 'distal' body sites, near the ankle contralesional to the more affected hand
Number of subjects: 80

Group type: COMPARATOR
Intervention: Local sham electro-acupuncture using non-penetrating placebo needles
Number of subjects: 80
Study: 26404947

Group type: EXPERIMENTAL
Intervention: Brushing with regular fluoride toothpaste followed by rinsing with a 0.075% cetylpyridinium chloride (CPC) mouthwash
Number of subjects: 70

Group type: COMPARATOR
Intervention: Brushing with regular fluoride toothpaste alone (control group)
Number of subjects: 70
Study: 23649906

Group type: EXPERIMENTAL
Intervention: Acidic saline (pH 3.3) injection
Number of subjects: 18

Group type: COMPARATOR
Intervention: Regular isotonic saline injection
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Repeated injection of acidic saline
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Injections (both acidic and regular saline)
Number of subjects: 18
Study: 20220040

Group type: COMPARATOR
Intervention: L-DOPS + Placebo (PLA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: L-DOPS + Entacapone (ENT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L-DOPS + Carbidopa (CAR)
Number of subjects: 12
Study: 19451574

Group type: EXPERIMENTAL
Intervention: Pulse cyclophosphamide, 15 mg/kg every 2 to 3 weeks
Number of subjects: 149

Group type: COMPARATOR
Intervention: Daily oral cyclophosphamide, 2 mg/kg per day
Number of subjects: 149
Study: 16797591

Group type: EXPERIMENTAL
Intervention: Antipsychotic treatment
Number of subjects: 172
Study: 15801333

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 11355559

Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg twice a day, in 3 cycles of 6 weeks with 2 weeks between cycles)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 29
Study: 9417436

Group type: EXPERIMENTAL
Intervention: Ionomeric cement used for reconstruction of the ossicular chain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Titanium-gold-angle prostheses crimped to the long process of the incus
Number of subjects: 0
Study: 7952663

Group type: EXPERIMENTAL
Intervention: Asymmetrical tibial prosthetic base plate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercial prosthesis
Number of subjects: 0
Study: 3570029

Group type: EXPERIMENTAL
Intervention: Lactitol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 6

Group type: COMPARATOR
Intervention: Neomycin with lactulose
Number of subjects: 6
Study: 2506091

Group type: EXPERIMENTAL
Intervention: Insulin therapy (twice daily for 6 months)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Glibenclamide and metformin combination therapy (for 6 months)
Number of subjects: 24
Study: 4599014

Group type: EXPERIMENTAL
Intervention: Midrin (M)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Isometheptene mucate (I)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 60
Study: 30771133

Group type: EXPERIMENTAL
Intervention: SMS intervention (35 HIV risk reduction and HIV testing SMSs over a 6-month period)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 28561278

Group type: EXPERIMENTAL
Intervention: Testosterone treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 100
Study: 25714579

Group type: COMPARATOR
Intervention: Vitamin E, Metformin, or Placebo (Control) for 96 weeks
Number of subjects: 173
Study: 23429997

Group type: EXPERIMENTAL
Intervention: Group A: pedicle screws
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Group B: long-head pedicle screws
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Group C: additional Ponte osteotomy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Group B and C
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 36
Study: 21829197

Group type: EXPERIMENTAL
Intervention: Lapatinib
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 19900934

Group type: EXPERIMENTAL
Intervention: Intervention group (detailed training programme before discharge and at five follow‐up visits during 24 months)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Control group (follow‐up visits without instructions in physical activity)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 314

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 314
Study: 17118858

Group type: EXPERIMENTAL
Intervention: Home exercise, walking exercise, group exercise, and self-care exercise
Number of subjects: 555

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 555
Study: 15006954

Group type: EXPERIMENTAL
Intervention: Moxifloxacin (400 mg qd for 5 days)
Number of subjects: 730

Group type: COMPARATOR
Intervention: Standard therapy (amoxicillin [500 mg tid for 7 days], clarithromycin [500 mg bid for 7 days], or cefuroxime‐axetil [250 mg bid for 7 days])
Number of subjects: 730
Study: 11396202

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol supplementation
Number of subjects: 606

Group type: COMPARATOR
Intervention: CYP1A1 genotype
Number of subjects: 606
Study: 9422470

Group type: EXPERIMENTAL
Intervention: G‐CSF 10 microg/kg/day + GM‐CSF 5 microg/kg/day (arm II)
Number of subjects: 50

Group type: COMPARATOR
Intervention: G‐CSF 10 microg/kg/day alone (arm I)
Number of subjects: 50
Study: 8486084

Group type: EXPERIMENTAL
Intervention: Propofol (0.2‐0.6 mg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3322376

Group type: EXPERIMENTAL
Intervention: Epostane (progesterone synthesis inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study: 31345146

Group type: EXPERIMENTAL
Intervention: Folic acid plus vitamin B12
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Folic acid alone
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Vitamin B12 alone
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 240
Study: 28321455

Group type: EXPERIMENTAL
Intervention: Brief Intervention for khat users
Number of subjects: 330
Study: 25907821

Group type: EXPERIMENTAL
Intervention: Optimized medical treatment of COPD
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Follow-up in pulmonary clinic for 24 weeks
Number of subjects: 130
Study: 23294275

Group type: COMPARATOR
Intervention: Rivaroxaban (10 mg) in subjects with mild hepatic impairment
Number of subjects: 32

Group type: COMPARATOR
Intervention: Rivaroxaban (10 mg) in subjects with moderate hepatic impairment
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Healthy subjects
Number of subjects: 32
Study: 21199175

Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg intravenously)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 18068522

Group type: EXPERIMENTAL
Intervention: Aspirin (75 mg enteric-coated tablet per day)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 310

Group type: COMPARATOR
Intervention: Control (aspirin avoidance)
Number of subjects: 310
Study: 16595222

Group type: EXPERIMENTAL
Intervention: rosiglitazone (4 mg twice daily) and clomiphene citrate (100 mg from the third day for 5 days)
Number of subjects: 25

Group type: COMPARATOR
Intervention: metformin (500 mg three times daily) and clomiphene citrate (100 mg from the third day for 5 days)
Number of subjects: 25
Study: 12914827

Group type: EXPERIMENTAL
Intervention: Counseling on physical activity and individual counseling on healthy food habits (intervention group)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Reference group (no intervention)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 169
Study: 10489668

Group type: EXPERIMENTAL
Intervention: Accuhaler
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Autohaler
Number of subjects: 0

Group type: COMPARATOR
Intervention: Turbuhaler
Number of subjects: 0
Study: 8613267

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brain natriuretic peptide (BNP) infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of ANP and BNP infusions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1748538

Group type: EXPERIMENTAL
Intervention: 250 mg intravenous metronidazole
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1.0 gm intravenous metronidazole
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 2.0 gm intravenous metronidazole
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Higher doses of metronidazole (1.0 gm and 2.0 gm)
Number of subjects: 9
Study: 6412738

Group type: EXPERIMENTAL
Intervention: Topical steroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of steroids and SCG
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27464622

Group type: EXPERIMENTAL
Intervention: WI9 (8.6 ± 0.2°C)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: WI15 (14.6 ± 0.3°C)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: WI35 (35.0 ± 0.4°C)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Passive rest (CON)
Number of subjects: 9
Study: 27152579

Group type: EXPERIMENTAL
Intervention: Double small incisions (Group A)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Standard incision (Group B)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Endoscopic release (Group C)
Number of subjects: 207
Study: 24823696

Group type: EXPERIMENTAL
Intervention: Axitinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Axitinib and Sorafenib
Number of subjects: 0
Study: 21041836

Group type: EXPERIMENTAL
Intervention: Fluoridated artificial saliva (FS) at 1500 ppm fluoride treatment alone
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Fluoridated artificial saliva (FS) at 1500 ppm fluoride treatment combined with thermocycling (FS + Th)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 110
Study: 20430500

Group type: COMPARATOR
Intervention: Folate (15 mg/d)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Coadministration of folate (15 mg/d) and methylcobalamin (500 mug after each hemodialysis treatment 3 times weekly)
Number of subjects: 40
Study: 19186852

Group type: EXPERIMENTAL
Intervention: NaF group (1450 mg/L sodium fluoride dentifrice)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: MFP group (1450 mg/L sodium monofluorophosphate dentifrice)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Non-fluoride group (non-fluoride dentifrice)
Number of subjects: 305
Study: 15806596

Group type: EXPERIMENTAL
Intervention: PCD children
Number of subjects: 20
Study: 12024846

Group type: EXPERIMENTAL
Intervention: Active reflexology
Number of subjects: 40

Group type: COMPARATOR
Intervention: Simulated (placebo) reflexology
Number of subjects: 40
Study: 9485231

Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (15-g bolus + infusion of 1 g/h)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: High-dose tranexamic acid (10-g bolus + placebo infusion)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Normal saline solution (placebo)
Number of subjects: 134
Study: 7610155

Group type: EXPERIMENTAL
Intervention: 90-min exercise bout at an intensity of 60% VO2max
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Low RQ (high fat oxidation)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: High RQ
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Exercise RQ
Number of subjects: 11
Study: 2147014

Group type: EXPERIMENTAL
Intervention: Monophasic preparation containing ethinylestradiol and desogestrel (M‐DG)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Monophasic preparation containing ethinylestradiol and gestodene (M‐GD)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Triphasic preparation of ethinylestradiol and levonorgestrel (T‐LN)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 58
Study: 918356

Group type: EXPERIMENTAL
Intervention: Phentolamine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Isoprenaline
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Phentolamine + Isoprenaline
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Phentolamine (in non-responders)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Phentolamine (in allergic bronchial asthma)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Isoprenaline (in allergic bronchial asthma)
Number of subjects: 12
Study: 30984388

Group type: EXPERIMENTAL
Intervention: Receive a pen with the invitation pack (n = 648)
Number of subjects: 1862

Group type: COMPARATOR
Intervention: No pen with the invitation pack (n = 1295)
Number of subjects: 1862
Study: 28436154

Group type: EXPERIMENTAL
Intervention: Home-based exercise program (n = 219)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Control group (n = 220)
Number of subjects: 439